12 Month Price Forecast For LFST
Distance to LFST Price Forecasts
LFST Price Momentum
🤔 Considering LifeStance (LFST)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 22, 2025 11:27 PM UTC
LFST Analyst Ratings & Price Targets
Based on our analysis of 8 Wall Street analysts, LFST has a consensus that is bullish. The median price target is $9.00, with forecasts ranging from $7.00 to $10.00. Currently, there are 4 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
With LFST currently trading at $8.00, the median price forecast suggests a 12.5% upside. The most optimistic forecast comes from Jamie Perse at Goldman Sachs, projecting a 25.0% upside, while Stephanie Davis at Barclays provides the most conservative target, suggesting a -12.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LFST Analyst Consensus
LFST Price Target Range
Latest LFST Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LFST.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 16, 2024 | Goldman Sachs | Jamie Perse | Buy | Upgrade | $10.00 |
| Nov 11, 2024 | Barclays | Stephanie Davis | Underweight | Maintains | $7.00 |
| Aug 15, 2024 | UBS | Kevin Caliendo | Neutral | Maintains | $7.50 |
| Aug 9, 2024 | Barclays | Stephanie Davis | Underweight | Maintains | $6.00 |
| Apr 22, 2024 | Morgan Stanley | Ricky Goldwasser | Overweight | Reiterates | $10.00 |
| Mar 6, 2024 | Jefferies | Brian Tanquilut | Buy | Maintains | $9.00 |
| Mar 4, 2024 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $9.00 |
| Feb 29, 2024 | Barclays | Underweight | Maintains | $8.00 | |
| Nov 22, 2023 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $8.00 |
| Nov 17, 2023 | JP Morgan | Lisa Gill | Neutral | Maintains | $8.00 |
| Aug 10, 2023 | JP Morgan | Lisa Gill | Neutral | Maintains | $10.00 |
| Jul 13, 2023 | Morgan Stanley | Overweight | Reiterates | $0.00 | |
| May 19, 2023 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $9.00 |
| May 11, 2023 | Morgan Stanley | Ricky Goldwasser | Overweight | Maintains | $10.00 |
| Jan 6, 2023 | Morgan Stanley | Ricky Goldwasser | Overweight | Upgrade | $8.00 |
| Nov 15, 2022 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $8.00 |
| Nov 14, 2022 | Cowen & Co. | Gary Taylor | Outperform | Maintains | $8.00 |
| Nov 7, 2022 | Jefferies | Brian Tanquilut | Buy | Assumes | $0.00 |
| Aug 22, 2022 | Cowen & Co. | Gary Taylor | Outperform | Maintains | $10.00 |
| May 10, 2022 | Morgan Stanley | Ricky Goldwasser | Equal-Weight | Maintains | $8.00 |
Stocks Similar to LifeStance Health Group, Inc.
The following stocks are similar to LifeStance based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
LifeStance Health Group, Inc. (LFST) Financial Data
LifeStance Health Group, Inc. has a market capitalization of $3.06B with a P/E ratio of -15.6x. The company generates $1.21B in trailing twelve-month revenue with a -7.9% profit margin.
Revenue growth is +19.0% quarter-over-quarter, while maintaining an operating margin of +0.1% and return on equity of -6.6%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
LifeStance Health Group, Inc. (LFST) Company Overview
About LifeStance Health Group, Inc.
Provides outpatient mental health services in the US.
The company operates a network of outpatient facilities that offer various mental health services, including evaluations, testing, and therapy for a diverse range of mental health conditions. LifeStance generates revenue through patient fees for these services, which can be accessed both virtually and in-person, catering to a broad patient demographic.
Founded in 2017 and based in Scottsdale, Arizona, the company is positioned to address the increasing demand for mental health services in the United States, particularly in light of rising awareness and acceptance of mental health issues.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
7,269
CEO
Mr. Kenneth Alan Burdick
Country
United States
IPO Year
2021
Website
lifestance.comLifeStance Health Group, Inc. (LFST) Latest News & Analysis
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), indicating increased optimism about its earnings prospects.
A Zacks Rank #1 upgrade signals strong earnings potential for LifeStance Health, likely attracting more investor interest and potentially driving up the stock price.
A new outpatient pediatric care model integrates primary and specialty care with advanced technology, aiming to enhance patient experiences and reduce physician burnout.
The new outpatient pediatric care model could enhance patient outcomes and operational efficiency, potentially boosting healthcare provider profits and attracting investments in innovative health tech.
Best Cheap Stocks To Buy Now (Under $10)
2 months agoFive stocks priced at or under $10 are highlighted for investors willing to take on the risk associated with inexpensive shares.
Cheap stocks under $10 can offer high upside potential but also come with increased risk. Identifying strong picks may lead to significant gains for risk-tolerant investors.
LifeStance Health Group, Inc. (NASDAQ:LFST) will hold its Q3 2024 earnings conference call on November 7, 2024, at 8:30 AM ET, featuring key executives and financial analysts.
The Q3 earnings call provides insights into LifeStance's financial performance and future guidance, influencing stock valuation and investor sentiment.
LifeStance Reports Third Quarter 2024 Results
2 months agoLifeStance Health Group, Inc. (Nasdaq: LFST) reported its financial results for Q3 2024, ending September 30. Further details on performance are available in the full report.
LifeStance Health's Q3 financial results can signal growth or challenges in the mental healthcare sector, impacting stock performance and investor sentiment in healthcare investments.
LifeStance Health Group (LFST) reported a quarterly loss of $0.02 per share, better than the estimated loss of $0.07, and improved from a loss of $0.17 per share a year prior.
LifeStance Health's smaller-than-expected quarterly loss could indicate improving financial health, potentially boosting investor confidence and affecting stock performance positively.
Frequently Asked Questions About LFST Stock
What is LifeStance Health Group, Inc.'s (LFST) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, LifeStance Health Group, Inc. (LFST) has a median price target of $9.00. The highest price target is $10.00 and the lowest is $7.00.
Is LFST stock a good investment in 2025?
According to current analyst ratings, LFST has 4 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $8.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for LFST stock?
Wall Street analysts predict LFST stock could reach $9.00 in the next 12 months. This represents a 12.5% increase from the current price of $8.00. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is LifeStance Health Group, Inc.'s business model?
The company operates a network of outpatient facilities that offer various mental health services, including evaluations, testing, and therapy for a diverse range of mental health conditions. LifeStance generates revenue through patient fees for these services, which can be accessed both virtually and in-person, catering to a broad patient demographic.
What is the highest forecasted price for LFST LifeStance Health Group, Inc.?
The highest price target for LFST is $10.00 from Jamie Perse at Goldman Sachs, which represents a 25.0% increase from the current price of $8.00.
What is the lowest forecasted price for LFST LifeStance Health Group, Inc.?
The lowest price target for LFST is $7.00 from Stephanie Davis at Barclays, which represents a -12.5% decrease from the current price of $8.00.
What is the overall LFST consensus from analysts for LifeStance Health Group, Inc.?
The overall analyst consensus for LFST is bullish. Out of 8 Wall Street analysts, 4 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $9.00.
How accurate are LFST stock price projections?
Stock price projections, including those for LifeStance Health Group, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
